The purpose of this application is to request a grant to support the BC Cancer Agency - Vancouver in becoming a major SWOG centre. The application provides justification and information to support our grant application.
Inclusion of the BC Cancer Agency Vancouver Cancer Centre as a SWOG member would give BC patients access to a much broader range of clinical trials, with the potential to significantly improve their outcomes. A successful membership application would also benefit the wider SWOG group by enhancing accrual to Group trials, and providing access to the Agency's outstanding clinical trials resources and infrastructure.
|Mahadevan, Daruka; Unger, Joseph M; Spier, Catherine M et al. (2013) Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350. Cancer 119:371-9|